Cart
sales@molnova.com
(2-Chloropyridin-4-yl)methanamine hydrochloride
CAS No. 916210-98-5
(2-Chloropyridin-4-yl)methanamine hydrochloride( —— )
Catalog No. M20701 CAS No. 916210-98-5
(2-Chloropyridin-4-yl)methanamine hydrochloride is a selective LOXL2 inhibitor(IC50 : 126 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 61 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(2-Chloropyridin-4-yl)methanamine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief Description(2-Chloropyridin-4-yl)methanamine hydrochloride is a selective LOXL2 inhibitor(IC50 : 126 nM).
-
Description(2-Chloropyridin-4-yl)methanamine hydrochloride is a selective LOXL2 inhibitor(IC50 : 126 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMAO
-
RecptorLOXL2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number916210-98-5
-
Formula Weight179.05
-
Molecular FormulaC6H8Cl2N2
-
Purity>98% (HPLC)
-
SolubilityDMSO:33 mg/mL (184.31 mM)
-
SMILESCl.NCc1ccnc(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hutchinson J H Rowbottom M W Lonergan D et al. Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX[J]. ACS Medicinal Chemistry Letters 2017 8(4):423-427.
molnova catalog
related products
-
hMAO-B-IN-4
hMAO-B-IN-4 is a selective, reversible and blood–brain barrier (BBB) penetrable inhibitor of human monoamine oxidase-B (hMAO-B, IC50=0.067 μM, Ki= 0.03 μM, hMAO-A, IC50= 33.82 μM).
-
MAO-B-IN-17
MAO-B-IN-17 is a selective and potent monoamine oxidase B (MAO-B) inhibitor (IC50: 5.08 μM) used in the study of central nervous system disorders, including Parkinson's.
-
Esuprone
Esuprone (LU-43839) is a novel reversible and highly selective MAO-A inhibitor with anticonvulsant activity for the treatment of depression.
